50 Most Influential Clinical Executives - 2020

Parsey joined the pharmaceutical company in 2019 from Genentech. He oversees global clinical development and medical affairs, including clinical trials. The company’s antirviral drug remdesivir, originally developed for hepatitis C and Ebola, showed early promise in speeding recovery for patients with COVID-19. A National Institutes of Health-funded study published in late May detailed some of the drug’s limitations, mainly that it worked best on patients who needed oxygen supplementation, not a ventilator.